INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 09, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 14,376 |
| Nov 09, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,599 |
| Nov 09, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 10,000 |
| Nov 04, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 2,282 |
| Nov 04, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 92,947 |
| Nov 04, 2015 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 1,203 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
| Nov 03, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 569,588 |
| Sep 22, 2015 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 18,349 |
| Sep 03, 2015 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,681 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.